Skip to content

Comparative clinical study to find out effectiveness of Katphaladi Ghanvati and Tablet Azithromycin to reduce pain while swallowing and erythema in pharynx seen in Acute Pharyngitis

Comparative Clinical Study of Katphaladi Ghanvati and Tablet Azithromycin in the management of Galgrah Vyadhi(Acute Pharyngitis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074021
Enrollment
60
Registered
2024-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J029- Acute pharyngitis, unspecified

Interventions

None listed

Sponsors

Dr Manasi Sanjay Deshmukh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with sign and symptoms like pain while swallowing / difficulty in swallowing fever malaise headache 18 to 60 years

Exclusion criteria

Exclusion criteria: Patients having other complications such as acute retropharyngeal abscess pharyngeal abscess otitis media etc. Patient who need surgical intervention. Pregnant & Lactating woman. Patient suffering from any other co-morbidities like severe hypertension malignancy heart diseases asthma.

Design outcomes

Primary

MeasureTime frame
To assess efficacy of Katphaladi Ghanvati in comaprison with Azithromycin in the management of Galgrah (Acute Pharyngitis)Timepoint: 5 days with 2 assessments (0 and 6)

Secondary

MeasureTime frame
To observe adverse effects of Katphaladi Ghanvati if anyTimepoint: 5 days with 2 assessments (0 and 6)

Countries

India

Contacts

Public ContactManasi Sanjay Deshmukh

Dr D Y Patil College Of Ayurved And Research Centre

mayur.shiralkar@dpu.edu.in9422007951

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026